Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page
- Check2 days agoChange DetectedRelated topics on the page were expanded to include 'Multiple myeloma' and a link to 'MedlinePlus Genetics'. This addition enhances navigation by connecting the study page to broader disease and genetics information.SummaryDifference0.2%

- Check9 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2. This represents a minor page version update and does not modify study data or the information presented to users.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, reflecting an internal site update.SummaryDifference0.1%

- Check31 days agoChange DetectedEnrollment status indicates no new participants are being sought, and new help sections were added alongside a formatting adjustment to the Intervention/Treatment label and a revision bump to v3.6.0.SummaryDifference0.5%

- Check38 days agoChange DetectedA new revision tag 'Revision: v3.5.5' was added, and 'Multiple myeloma', 'related topics' (including MedlinePlus Genetics), and the earlier revision tag 'Revision: v3.5.4' were removed, indicating a cleanup of page metadata.SummaryDifference0.2%

- Check45 days agoChange DetectedAdded a related topics block for Multiple myeloma under MedlinePlus Genetics on the study page, providing access to additional health information about the condition.SummaryDifference0.2%

Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.